Pesquisa | Biblioteca Virtual em Saúde

1.

Revitalizing monoamine oxidase inhibitors: a call for action.

Gillman, P Ken; Feinberg, S Shalom; Fochtmann, Laura J.

CNS Spectr ; 25(4): 452-454, 2020 08.

Artigo em Inglês | MEDLINE | ID: mdl-31272520

2.

Neuroleptic malignant syndrome: mechanisms, interactions, and causality.

Gillman, P Ken.

Mov Disord ; 25(12): 1780-90, 2010 Sep 15.

Artigo em Inglês | MEDLINE | ID: mdl-20623765

3.

Triptans, serotonin agonists, and serotonin syndrome (serotonin toxicity): a review.

Gillman, P Ken.

Headache ; 50(2): 264-72, 2010 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-19925619

4.

Serotonin toxicity associated with the use of linezolid: a review of postmarketing data.

Lawrence, Kenneth R; Adra, May; Gillman, P Ken.

Clin Infect Dis ; 42(11): 1578-83, 2006 Jun 01.

Artigo em Inglês | MEDLINE | ID: mdl-16652315

5.

A review of serotonin toxicity data: implications for the mechanisms of antidepressant drug action.

Gillman, P Ken.

Biol Psychiatry ; 59(11): 1046-51, 2006 Jun 01.

Artigo em Inglês | MEDLINE | ID: mdl-16460699

6.

'Withdrawal neuroleptic malignant syndrome': a phantom explanatory cause for a fatality.

Gillman, P Ken.

Med Sci Law ; 51(2): 122-3; author reply 124, 2011 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-21793478

7.

More on Mrs Murphy's beans: or "Do us a fava".

Gillman, P Ken.

J Clin Psychopharmacol ; 30(2): 215-6, 2010 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-20520305

8.

Methylene blue and serotonin toxicity: definite causal link.

Gillman, P Ken.

Psychosomatics ; 51(5): 448-9, 2010.

Artigo em Inglês | MEDLINE | ID: mdl-20833947

9.

Neuroleptic malignant syndrome: half a century of uncertainty suggests a Chimera.

Gillman, P Ken.

Pharmacoepidemiol Drug Saf ; 19(8): 876-7, 2010 Aug.

Artigo em Inglês | MEDLINE | ID: mdl-20665596

10.

Is there sufficient evidence to suggest cyclobenzaprine might be implicated in causing serotonin toxicity?

Gillman, P Ken.

Am J Emerg Med ; 27(4): 509-10; author reply 510, 2009 May.

Artigo em Inglês | MEDLINE | ID: mdl-19555629

11.

Lessons continue: serotonin toxicity.

Gillman, P Ken.

Consult Pharm ; 24(7): 474-6; author reply 476-7, 2009 Jul.

Artigo em Inglês | MEDLINE | ID: mdl-19694109

12.

CNS toxicity involving methylene blue: the exemplar for understanding and predicting drug interactions that precipitate serotonin toxicity.

Gillman, P Ken.

J Psychopharmacol ; 25(3): 429-36, 2011 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-20142303

13.

Patient Safety and Methylene Blue-Associated Severe Serotonin Toxicity.

Rosenbaum, Harvey K; Gillman, P Ken.

A A Case Rep ; 7(1): 1, 2016 Jul 01.

Artigo em Inglês | MEDLINE | ID: mdl-27415030

14.

Linezolid and serotonin toxicity.

Gillman, P Ken.

Clin Infect Dis ; 37(9): 1274-5, 2003 Nov 01.

Artigo em Inglês | MEDLINE | ID: mdl-14557977

15.

Amitriptyline: dual-action antidepressant?

Gillman, P Ken.

J Clin Psychiatry ; 64(11): 1391; author reply 1391-2, 2003 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-14658955

16.

Making sense of serotonin toxicity reports, a comment on Chopra et Al. (World J Biol Psychiatry 2004, 5: 114-115).

Gillman, P Ken.

World J Biol Psychiatry ; 5(3): 167-8, 2004 Jul.

Artigo em Inglês | MEDLINE | ID: mdl-15346543

17.

A systematic review of the serotonergic effects of mirtazapine in humans: implications for its dual action status.

Gillman, P Ken.

Hum Psychopharmacol ; 21(2): 117-25, 2006 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-16342227

18.

Neuroleptic malignant syndrome, poor science and inaccurate measurements.

Gillman, P Ken.

J Psychopharmacol ; 25(6): 850, 2011 Jun.

Artigo em Inglês | MEDLINE | ID: mdl-20488833

19.

Bupropion, bayesian logic and serotonin toxicity.

Gillman, P Ken.

J Med Toxicol ; 6(2): 276-7, 2010 Jun.

Artigo em Inglês | MEDLINE | ID: mdl-20440594

20.

The nature of hyperthermia in neuroleptic malignant syndrome and the use of bromocriptine.

Gillman, P Ken.

J Med Toxicol ; 6(2): 272-3, 2010 Jun.

Artigo em Inglês | MEDLINE | ID: mdl-20361363

Biblioteca Virtual em Saúde

Saúde Pública Brasil

Sua seleção (0)

Formato de exportação:

Exportar:

Revitalizing monoamine oxidase inhibitors: a call for action.

Neuroleptic malignant syndrome: mechanisms, interactions, and causality.

Triptans, serotonin agonists, and serotonin syndrome (serotonin toxicity): a review.

Serotonin toxicity associated with the use of linezolid: a review of postmarketing data.

A review of serotonin toxicity data: implications for the mechanisms of antidepressant drug action.

'Withdrawal neuroleptic malignant syndrome': a phantom explanatory cause for a fatality.

More on Mrs Murphy's beans: or "Do us a fava".

Methylene blue and serotonin toxicity: definite causal link.

Neuroleptic malignant syndrome: half a century of uncertainty suggests a Chimera.

Is there sufficient evidence to suggest cyclobenzaprine might be implicated in causing serotonin toxicity?

Lessons continue: serotonin toxicity.

CNS toxicity involving methylene blue: the exemplar for understanding and predicting drug interactions that precipitate serotonin toxicity.

Patient Safety and Methylene Blue-Associated Severe Serotonin Toxicity.

Linezolid and serotonin toxicity.

Amitriptyline: dual-action antidepressant?

Making sense of serotonin toxicity reports, a comment on Chopra et Al. (World J Biol Psychiatry 2004, 5: 114-115).

A systematic review of the serotonergic effects of mirtazapine in humans: implications for its dual action status.

Neuroleptic malignant syndrome, poor science and inaccurate measurements.

Bupropion, bayesian logic and serotonin toxicity.

The nature of hyperthermia in neuroleptic malignant syndrome and the use of bromocriptine.